Hormone-dependent breast cancer in postmenopausal women.

Analieva 1mg
| MRP | : |
|
| Price | : | ₹79.00 |
| You Save | : | ₹502.25 (86.41%) |
10 Tablet(s) In A Strip
Analieva 1mg Tablet is an anticancer medication containing Anastrozole. It falls under the category of aromatase inhibitors. This drug is prescribed for the treatment of hormone-dependent breast cancer in postmenopausal women. Aromatase inhibitors work by lowering estrogen levels, as they inhibit an enzyme in adipose tissue that converts other hormones into estrogen. This treatment aids in postponing the recurrence of early-stage breast cancer.
Common side effects include nausea, vomiting, decreased appetite, fever, itching, joint inflammation (arthritis), bone density loss (osteoporosis), vaginal bleeding, hypersensitivity, and pain in the joints, stomach, and kidneys.
If you have an allergy to Anastrozole or any of its components, inform your doctor prior to commencing treatment with this drug. Additionally, notify your doctor if you are still menstruating and have not yet reached menopause, if you have osteoporosis, or if you have any liver or kidney issues. If you are lactose intolerant, please consult your physician before using this medication. This medicine should not be taken if you are pregnant or nursing.